20051004
 Abbott Laboratories: FDA Approves Arthritis Drug For First-Line Treatment   The Wall Street Journal,  Oct 5, 2005  Abbott Laboratories received Food and Drug Administration approval to market its Humira drug for first-line treatment of rheumatoid arthritis and to treat psoriatic arthritis, an autoimmune disease that causes joint pain in the hands, feet and wrists and often leads to...  Abbott Laboratories received Food and Drug Administration approval to market its Humira drug for first-line treatment of rheumatoid arthritis and to treat psoriatic arthritis, an autoimmune disease that causes joint pain in the hands, feet and wrists and often leads to...   
